Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenyl-2-ylamino)phenyl)propyl scaffold - SURE

What are you looking for today?

Gomaa, M., Bridgens, C., Illingworth, N., Veal, G. J., Redfern, C. P. F., Brancale, A, Armstrong, Jane and Simons, C. (2012) Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenyl-2-ylamino)phenyl)propyl scaffold. Bioorganic & Medicinal Chemistry, 20 (14). pp. 4201-4207. ISSN 0968-0896

Full text not available from this repository. (Request a copy)

Abstract

Official URL: http://www.sciencedirect.com/science/article/pii/S...

Item Type:	Article
Depositing User:	Glenda Young
URI:	https://sure.sunderland.ac.uk/id/eprint/3296

Further Details

More Information

Depositing User

Identifiers

Item ID

3296

Identification Number

10.1016/j.bmc.2012.05.076

ISSN

0968-0896

Users with ORCIDS

ORCID for Jane Armstrong

orcid.org/0000-0002-5822-0597

Catalogue record

Date Deposited

08 Jan 2013 09:29

Last Modified

04 Jun 2025 17:36

Contributors

Author

Jane Armstrong ORCID iD

Author

M. Gomaa

Author

C. Bridgens

Author

N. Illingworth

Author

G. J. Veal

Author

C. P. F. Redfern

Author

A Brancale

Author

C. Simons

University Divisions

Faculty of Health Sciences and Wellbeing > Pharmacy and Pharmaceutical Sciences
Faculty of Health Sciences and Wellbeing > School of Nursing and Health Sciences
Faculty of Health Sciences and Wellbeing

Subjects

Sciences > Pharmacy and Pharmacology

Actions (login required)

Dimensions

Altmetric